COMMUNIQUÉS West-GlobeNewswire

Phase 2 Ready Oncology Drug Receives FDA Orphan Drug Designation
17/09/2018
SAN DIEGO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX) (“Cytori” or the “Company”) today announced that it received FDA orphan drug designation for its ATI-1123 chemotherapy drug product [...]
Medtronic Joins Catalyst CEO Champions For Change and Pledges to Accelerate Women Into Management and Board Seats
17/09/2018
Medtronic CEO Omar Ishrak Commits to Continue Accelerating Diversity, Inclusion and Gender Equality DUBLIN - September 17, 2018 - Medtronic plc (NYSE:MDT) today announced it has joined the Catalyst CEO Champions For [...]
ATW Tech Signs a Letter of Intent for the Divestiture of Its Atman Assets
17/09/2018
MONTREAL, Sept. 17, 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (TSX-V: ATW) announces today that its fully-owned subsidiary InformationTelcharge.com (‘Atman’) signed a letter of intent to divest some of its assets to Marie- [...]
ATW Tech signe une lettre d’intention pour la vente des actifs d’Atman
17/09/2018
MONTRÉAL, 17 sept. 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (la « Société » ou « ATW Tech ») (TSX-V : ATW) annonce aujourd’hui la signature par sa filiale exclusive InformationTelcharge.com (« Atman ») visant la vente de [...]
Comprehensive Pharmacy Services Named Best Pharmacy Support Services Provider – USA
17/09/2018
Global Health and Pharma Recognizes Comprehensive Pharmacy Services in 2018 Healthcare & Pharmaceutical Awards MEMPHIS, Tenn., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Global Health & Pharma (GHP) has selected [...]
Avadim Technologies Announces Name Change To Avadim Health, Inc.
17/09/2018
Name Change To Reflect Company Vision – “To Take Healing To The Nations” ASHEVILLE, N.C., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Avadim Technologies Inc. (“Avadim”), the Bionome Therapies TM life sciences company, announced [...]
Transactions under Novozymes’ stock buyback program
17/09/2018
Please read the full announcement in the attached PDF Attachment 2018_54_Stock_Buybackprogram_EN
PSI’s Acquisition of KINEX Strengthens Company’s Position as an IT Leader
17/09/2018
ARLINGTON, Va., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Planned Systems International, Inc. (PSI) is pleased to announce that it has acquired KINEX, Inc., a company in business for over 20 years providing mission-critical [...]
GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions
17/09/2018
Villepinte (France), le 17 septembre 2018 Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018 [...]
Extendicare Announces September 2018 Dividend of C$0.04 per Share
17/09/2018
MARKHAM, Ontario, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]
New Independent Data Further Demonstrates Clinical Utility of Daxor Corporation’s Blood Volume Analyzer (BVA-100) Over Surrogate Measurements
17/09/2018
NEW YORK, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today [...]
Ultragenyx Expands Leadership Team and Appoints Dr. Wladimir Hogenhuis as Chief Operating Officer
17/09/2018
NOVATO, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]
FDA Grants Rare Pediatric Disease Designation to Cellectar Biosciences’ CLR 131 for the Treatment of Osteosarcoma
17/09/2018
MADISON, Wis., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the [...]
Menlo Therapeutics Begins European Prurigo Nodularis Phase 3 Trial and Presents Additional Data from PN Phase 2 Trial at EADV
17/09/2018
~Additional Exploratory Analyses of Phase 2 Clinical Trial of Serlopitant in Prurigo Nodularis Presented at the European Academy of Dermatology and Venereology Congress~ REDWOOD CITY, Calif., Sept. 17, 2018 (GLOBE [...]
Novo Nordisk A/S - Share repurchase programme
17/09/2018
Bagsværd, Denmark, 17 September 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]
Avivagen Announces Approval from TSX Venture Exchange for Extension of Warrants
17/09/2018
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. OTTAWA, Sept. 17, 2018 (GLOBE NEWSWIRE) -- [...]
Tabula Rasa HealthCare’s Newly Acquired Subsidiary, Mediture, Expands Managed Long-term Care Services with Visiting Nurse Service of New York
17/09/2018
MOORESTOWN, N.J., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC) , a healthcare technology company advancing the field of medication safety, today announced its subsidiary, [...]
Apotheca Biosciences (PCFP) Overviews Pain-Patch, an Opioid Substitution
17/09/2018
Saint Petersburg, FL, Sept. 17, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Apotheca Biosciences (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, drug formulations and cannabis delivery [...]
VBL Therapeutics to Present at Upcoming Conferences in October
17/09/2018
TEL AVIV, Israel, Sept. 17, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Pages